Zane Ābola

Medicine & Life Sciences

1. Tissue Inhibitor of Metalloproteinase-2 100%
2. Necrotizing Enterocolitis 92%
3. Child 74%
4. Matrix Metalloproteinase 2 73%
5. Vascular Endothelial Growth Factor A 53%
6. human DEFB4A protein 52%
7. Interleukin-7 51%
8. Latvia 51%
9. Matrix Metalloproteinase Inhibitors 51%
10. Gastric Dilatation 51%
11. Interleukin-8 42%
12. Interleukin-4 41%
13. Interleukin-10 41%
14. Hepatocyte Growth Factor 39%
15. Premature Infants 37%
16. Fibroblast Growth Factor 2 35%
17. Interleukin-1 33%
18. Fibroblasts 31%
19. Transforming Growth Factors 30%
20. University Hospitals 29%
21. Newborn Infant 29%
22. Tumor Necrosis Factor-alpha 28%
23. Macrophages 27%
24. Intercellular Signaling Peptides and Proteins 27%
25. Parturition 26%
26. Birth Weight 25%
27. Interleukin-1alpha 24%
28. Interleukin-6 24%
29. Cytokines 23%
30. Extracellular Matrix 22%
31. Proteins 19%
32. Receptor, Fibroblast Growth Factor, Type 1 19%
33. Immunohistochemistry 18%
34. Transforming Growth Factor beta 18%
35. Enzymes 18%
36. Inflammation 15%
37. Pathology 14%
38. Gestational Age 13%
39. Reference Values 13%
40. Human Milk 12%
41. Anti-Inflammatory Agents 12%
42. Body Weight 11%
43. Tuberculin 11%
44. Connective Tissue Cells 11%
45. Therapeutics 11%
46. Infant Mortality 11%
47. Umbilical Hernia 11%
48. Nonparametric Statistics 10%
49. Inflammation Mediators 10%
50. Hospital Obstetrics and Gynecology Department 10%